Breakingviews - Vaccine shoves open door for year-end capital rush
LONDON (Reuters Breakingviews) - Hopes of a Covid-19 vaccine have already given equity capital markets bankers a boost. As stock markets soared after encouraging test results from Pfizer and BioNTech, companies in hard-hit sectors like travel and leisure rushed to top up their balance sheets. With the end of the year looming, smaller equity issues and instruments like convertible bonds may go down better than big, drawn-out offerings.
